BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.82 -0.37 (-4.52%) Market Cap: 1.62 Bil Enterprise Value: 2.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 12:30PM GMT
Release Date Price: $2.81 (-10.79%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone. My name is Gena Wan, I'm SMid-cap biotech analyst at the Barclays. In this very special situation, I first wish everyone stay healthy. And I would like to thank all the participants, including investors and companies and especially our event team and corporate access team, who made this virtual health care conference possible.

With that, I would like to introduce our first presenters, Jon Stonehouse, Chief Executive Officer; Bill Sheridan, Chief Medical Officer; Charlie Gayer, Chief Commercial Officer; and John Bluth, Senior VP of IR and Corporate Communications from BioCryst. There will be a slide presentation. I just wanted to mention to everyone you need to click physically to move to the next slide.

With that, I hand over to Jon.

Jon P. Stonehouse
BioCryst Pharmaceuticals, Inc. - CEO, President & Director

Thanks, Gena, and thanks for everyone joining this morning. Really appreciate Barclays' flexibility in being able to adjust the conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot